Abstracts tagged "management"

Abstract Number: 2387 • 2019 ACR/ARP Annual Meeting
Management of Patients with Incident Rheumatoid Arthritis in Rheumatology Clinical Practice
isabel Hernandez Rodriguez¹, Zulema Rosales Rosado ¹, pia Lois ¹, Cristina Lajas ¹, Judit Font Urgelles ², Juan Angel Jover Jover ¹ and lydia Abasolo Alcazar ¹, ¹HOSPITAL CLINICO SAN CARLOS, MADRID, Spain, ²HOSPITAL CLINICO SAN CARLOS, MADRID, Madrid, Spain
Background/Purpose: Treatment of Rheumatoid Arthritis (RA) has changed drastically in the last two decades in strategies and objectives, as well as in therapeutic options, especially…
Abstract Number: 1601 • 2018 ACR/ARHP Annual Meeting
Impact of Clinical Specialty Setting and Geographic Regions on Disease Management in Patients with Psoriatic Arthritis: Results from a Cross-Sectional Observational Study in the United States
Philip J. Mease¹, Clive Liu², Evan Siegel^3,4, Heather Richmond⁵, Meijing Wu⁶, Liang Chen⁶, Kevin Douglas⁶ and Benjamin Lockshin⁷, ¹Swedish Medical Center and University of Washington, Seattle, WA, ²Bellevue Dermatology Clinic, Bellevue, WA, ³Georgetown University, Washington, DC, ⁴Arthritis and Rheumatism Associates, Rockville, MD, ⁵Clear Dermatology, Houston, TX, ⁶AbbVie Inc., North Chicago, IL, ⁷US Dermatology Partners, Rockville, MD
Background/Purpose: In patients (pts) with psoriatic arthritis (PsA), early diagnosis and effective treatment has been shown to decrease functional disability and structural progression (Gladman DD,…
Abstract Number: 2338 • 2018 ACR/ARHP Annual Meeting
Pharmacological and Non-Pharmacological Approaches in a Group of Osteoporotic Patients Referring to a Rehabilitation out-Patient Clinic
Pinar Borman¹, ESRA GIZEM KOYUNCU¹, Aysegul Yaman¹ and MERVE PARLAK², ¹University of Hacettepe Faculty of Medicine, Dept of PMR, Ankara, Turkey, ²University of Hacettepe Faculty of Medicine, Dept of Public Health, Ankara, Turkey
Background/Purpose: Non-pharmacologic treatments are generally kept in the background in management of osteoporosis. The aim of this retrospective study was to evaluate characteristics and frequency…
Abstract Number: 347 • 2017 ACR/ARHP Annual Meeting
Disease Burden at One Academic Rheumatology Routine Care Setting Is Similar in Osteoarthritis (OA) and Rheumatoid Arthritis (RA) at First Visit but Significantly Greater in OA at a 6-Month Follow-up Visit
Jacquelin R. Chua¹, Shakeel M. Jamal¹, Isabel Castrejón¹, Najia Shakoor¹, Anne-Marie Malfait², Joel A. Block² and Theodore Pincus², ¹Division of Rheumatology, Rush University Medical Center, Chicago, IL, ²Rheumatology, Rush University Medical Center, Chicago, IL
Background/Purpose: Osteoarthritis commonly is regarded as less severe and less debilitating than RA. However, limited data are available for direct comparison of OA versus RA,…
Abstract Number: 1042 • 2017 ACR/ARHP Annual Meeting
Remote Management of Osteoporosis Screening and Treatment in US Veterans Using a Bone Health Team: A Cost-Effectiveness Analysis
Karla L. Miller¹, Jordan King², Phillip Lawrence³, Richard Nelson⁴, Joanne Lafleur⁵, Grant Cannon⁶ and Scott Nelson⁷, ¹Internal Medicine, Veterans Affairs Salt Lake City Health Care System and University of Utah School of Medicine, Salt Lake City, UT, ²Clinical Pharmacy Specialist, Research, Kaiser Permanente Colorado, Aurora, CO, ³Salt Lake City VA Medical Center and Roseman University of Health Sciences, Salt Lake City, UT, ⁴Epidemiology, Veterans Affairs Salt Lake City Health Care System and University of Utah School of Medicine, Salt Lake City, UT, ⁵University of Utah Department of Pharmacotherapy and Salt Lake City VA Medical Center, Salt Lake City, UT, ⁶Salt Lake City VA Medical Center and University of Utah, Salt Lake City, UT, ⁷Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN
Remote Management of Osteoporosis Screening and Treatment in US Veterans using a Bone Health Team: A Cost-effectiveness Analysis Background/Purpose: To evaluate the cost effectiveness of…
Abstract Number: 2727 • 2016 ACR/ARHP Annual Meeting
Evaluating Psoriatic Arthritis and Psoriasis Skin Lesions: Ultrasound As a Complementary Measure
Yogan Kisten¹, Per T Larsson², Erik af Klint², Hamed Rezaei^2,3, Noémi Györi¹, Liv Eidsmo⁴, Mona Ståhle⁴ and Ronald F. van Vollenhoven^1,5, ¹Department of Medicine, Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID), The Karolinska Institute, Stockholm, Sweden, ²Medicine, Rheumatology Unit, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden, ³Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID), The Karolinska Institute, Stockholm, Sweden, ⁴Dermatology and Venereology Unit, Department of Medicine, Karolinska Institute, Stockholm, Sweden, ⁵Amsterdam Rheumatology and Immunology Center (ARC), Amsterdam, Netherlands
Background/Purpose: The diagnosis and assessment of psoriatic arthritis (PsA) and psoriasis (PsO) lesions are mostly done by visual inspection, and when in doubt, supplemented by…
Abstract Number: 1953 • 2016 ACR/ARHP Annual Meeting
Management and Outcomes of ANCA-Associated Vasculitis in Unselected Cases within a Large Health Region of England
Fiona Pearce¹, Catherine McGrath², Ravinder Sandhu³, Jon Packham⁴, Karen Obrenovich⁵, Richard A. Watts⁶, Peter Lanyon⁷ and for the East Midlands, West Midlands and East of England regional audit groups, ¹Epidemiology and Public Health, University of Nottingham, Nottingham, United Kingdom, ²Department of Rheumatology, The Dudley Group NHS Foundation Trust, Dudley, United Kingdom, ³The Dudley Group NHS Foundation Trust, Dudley, Great Britain, ⁴University of Keele, Keele, United Kingdom, ⁵The Dudley Group NHS Foundation Trust, Dudley, United Kingdom, ⁶Rheumatology Department, Ipswich Hospital, Ipswich, Great Britain, ⁷Department of Rheumatology, Nottingham University Hospitals NHS trust, Nottingham, United Kingdom
Background/Purpose: Most data on management and outcomes of ANCA-associated vasculitis (AAV) come from highly selected populations in tertiary referral centres, or clinical trials. These results…
Abstract Number: 7L • 2015 ACR/ARHP Annual Meeting
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): Treatment Recommendations for Psoriatic Arthritis 2015
Laura C Coates^1,2, Arthur Kavanaugh³, Philip J. Mease⁴, Enrique R. Soriano⁵, M Laura Acosta-Felquer⁶, April W Armstrong⁷, Wilson Bautista-Molano⁸, Wolf-Henning Boehncke⁹, Willemina Campbell¹⁰, Alberto Cauli¹¹, Luis Espinoza¹², Oliver FitzGerald¹³, Dafna D. Gladman¹⁴, Alice B. Gottlieb¹⁵, Philip S. Helliwell², M. Elaine Husni¹⁶, Thorvardur Love^17,18, Ennio Lubrano¹⁹, Neil J McHugh²⁰, Peter Nash²¹, Alexis Ogdie-Beatty²², Ana-Maria Orbai²³, Andrew Parkinson²⁴, Denis O'Sullivan²⁵, Cheryl F Rosen²⁶, Sergio Schwartzman²⁷, Evan Siegel²⁸, Sergio Toloza²⁹, William Tuong³⁰ and Christopher T. Ritchlin³¹, ¹Medicine, University of Rochester, Rochester, NY, ²Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, ³University of California San Diego, La Jolla, CA, ⁴Rheumatology Research, Swedish Medical Center, Seattle, WA, ⁵Rheumatology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, ⁶Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, ⁷Keck School of Medicine, University of Southern California, Los Angeles, CA, ⁸Department of Rheumatology, Faculty of Medicine HMC/UMNG, Bogota, Colombia, Bogotá, Colombia, ⁹Department of Dermatology,, Geneva University Hospital, Geneva, Switzerland, ¹⁰Toronto Western Hospital, Toronto, ON, Canada, ¹¹University of Cagliari, Cagliari, Italy, ¹²Medicine-Section of Rheumatology, LSU Medical Center, New Orleans, LA, ¹³Department of Rheumatology, St. Vincent’s University Hospital, UCD School of Medicine and Medical Sciences and Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland, ¹⁴Division of Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, ¹⁵Tufts Medical Center, Boston, MA, ¹⁶Rheumatology Dept A50, Cleveland Clinic, Cleveland, OH, ¹⁷Faculty of Medicine, University of Iceland, Reykjavik, Iceland, ¹⁸Landspitali University Hospital, Reykjavík, Iceland, ¹⁹Cattedra di Reumatologia, Università del Molise, Campobasso, Italy, ²⁰Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom, ²¹Department of Medicine, University of Queensland, Brisbane, Australia, ²²Medicine/Rheumatology, Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, ²³Rheumatology, Johns Hopkins University, Baltimore, MD, ²⁴Chapel Allerton Hospital, Leeds, United Kingdom, ²⁵St. Vincent’s University Hospital, Dublin, Ireland, ²⁶Division of Dermatology, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, ²⁷Rheumatology, Hospital for Special Surgery, New York, NY, ²⁸Arthritis & Rheumatism Assoc, Wheaton, MD, ²⁹Rheumatology, Ministry of Health, San Fernando del Valle de Catamarca, Argentina, ³⁰Department of Dermatology, University of California David, Davis, CA, ³¹Allergy, Immunology and Rheumatololgy Division, University of Rochester Medical Center, Rochester, NY
Background/Purpose: Since the 2009 GRAPPA treatment recommendations were published, therapeutic options and management strategies for psoriatic arthritis (PsA) have advanced considerably. We updated and improved…
Abstract Number: 472 • 2015 ACR/ARHP Annual Meeting
Quality Assessment in Clinical Management of Patients with Rheumatoid Arthritis. Are We Using the “Treat to Target” Strategy?
Jose Luis Andreu^1,2, Maria Auxiliadora Martin³, H Corominas⁴, Jose Javier Perez Venegas⁵, Jose Andres Roman Ivorra^6,7, Angel Gil⁸, Fernando Sánchez-Alonso⁹, Tamara Jiménez¹⁰ and Miguel Angel Sánchez-Ruiz¹⁰, ¹Rheumatology, Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Spain, ²Rheumatology, HU Puerta de Hierro Majadahonda, Madrid, Spain, ³Research Unit of Spanish Society of Rheumatology,, Madrid, Spain, ⁴CapiCAT group (Nailfold Capillaroscopy group from the Catalan Society for Rheumatology)., Catalonia, Spain, ⁵Rheumatology, Hospital de Jerez de la Frontera, Jerez de la Frontera, Spain, ⁶Rheumatology, H.U. P. La Fe, Valencia, Spain, ⁷Servicio de Reumatología, Servicio de Reumatología Hospital Universitario La Fe, Valencia, Spain, ⁸Cátedra de Resultados en Salud, Universidad Rey Juan Carlos, Madrid, Spain, ⁹Unidad de Investigación. Sociedad Española de Reumatología, Madrid, Spain, ¹⁰Universidad Rey Juan Carlos, Madrid, Spain
Background/Purpose: The current paradigm of optimal clinical management of patients with rheumatoid arthritis (RA) recommends reaching a state of remission or low activity of the disease,…
Abstract Number: 1196 • 2015 ACR/ARHP Annual Meeting
Patient Education in Spondyloarthritis Should be Guiding, Reliable and Available and Presented in Varied Formats
Emma Haglund^1,2,3, Ann Bremander^1,2,3, Stefan Bergman^1,3,4 and Ingrid Larsson^3,5, ¹Department of Clinical Sciences, Lund, Section of Rheumatology, Lund University, Lund, Sweden, ²School of Business, Engineering and Science, Halmstad University, Halmstad, Sweden, ³Spenshult Research and Development Center, Halmstad, Sweden, ⁴Primary Health Care Unit, Department of Public Health and Community Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden, ⁵School of Health and Welfare, Halmstad University, Halmstad, Sweden
Background/Purpose: The treatment target for axial spondyloarthritis (SpA) is to maximize health-related quality of life (HRQoL) by controlling disease activity and improving functioning. The treatment…
Abstract Number: 2385 • 2015 ACR/ARHP Annual Meeting
Arthritis Management in Primary Care and Adherence to National Guidelines – a Swedish Survey Based on the Canadian Physiotherapists Arthritis Care Questionnaire
Siv Folkhammar Andersson¹, Stefan Bergman^2,3,4 and Ann Bremander^3,4,5, ¹Unit of Rehabilitation, Kalmar County Council, Samrehab, Oskarshamn, Sweden, Oskarshamn, Sweden, ²Primary Health Care Unit, Department of Public Health and Community Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden, ³Department of Clinical Sciences, Lund, Section of Rheumatology, Lund University, Lund, Sweden, ⁴FoU Spenshult, Halmstad, Sweden, ⁵School of Business, Engineering and Science, Halmstad University, Halmstad, Sweden
Background/Purpose: For patients with osteoarthritis (OA) physical therapy is recommended first line treatment and performed in primary care while patients with rheumatoid arthritis (RA) may…
Abstract Number: 2511 • 2015 ACR/ARHP Annual Meeting
Primary Care Management of Patients with Rheumatic Diseases Prior to Rheumatologist Consultation
Jessica Widdifield¹, J Carter Thorne², Karen Tu³, Debra Butt³, Noah Ivers⁴, Claire Bombardier⁴, R. Liisa Jaakkimainen⁵, Vandana Ahluwalia⁶, J. Michael Paterson⁷ and Sasha Bernatsky⁸, ¹McGill University, Montreal, QC, Canada, ²Southlake Regional Health Centre, Newmarket, ON, Canada, ³Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, ⁴University of Toronto, Toronto, ON, Canada, ⁵Preventive Med and Biostatisti, University of Toronto, Toronto, ON, Canada, ⁶Past President, Ontario Rheumatology Association, Brampton, ON, Canada, ⁷ICES, Toronto, ON, Canada, ⁸Rheum/Clin. Epid., McGill MUHC/RVH, Montreal, QC, Canada
Background/Purpose: Primary care physicians (PCP) often play a central role in the early detection and referral for patients with rheumatic diseases. Our aim was to…
Abstract Number: 682 • 2014 ACR/ARHP Annual Meeting
Impact of Patient’s Priorities on the Management of Systemic Lupus Erythematosus
Valérie Leclair¹, Holly O. Witteman², Carolyn Neville³, Isabelle Fortin⁴ and Paul R. Fortin⁵, ¹Internal Medicine, Laval University, Department of Internal Medicine, Quebec City, QC, Canada, ²Medicine, Laval University, Family and Emergency Medicine, Quebec City, QC, Canada, ³Epidemiology, Division of Clinical Epidemiology, Department of Medicine, McGill University Health Centre, Canada, Montreal, QC, Canada, ⁴Centre de Rhumatologie de l'Est du Québec, Rimouski, QC, Canada, ⁵Rheumatology, Laval University, Division of Rheumatology, Centre de Recherche du CHU de Québec and Department of Medicine, Quebec City, QC, Canada
Background/Purpose: Systemic Lupus Erythematosus (SLE) greatly reduces the quality of life (QoL) and satisfaction with life of affected patients. SLE patients can have numerous unmet…
Abstract Number: 2388 • 2013 ACR/ARHP Annual Meeting
Predictive Factors Of Relapse Or Persistent Stable Remission For Rheumatoid Arthritis (RA) Patients In Remission in a TNF Blocker-Spacing Strategy Trial (STRASS Trial)
Thao Pham¹, Jacques Morel², Toni Alfaiate³, Emmanuelle Dernis⁴, Philippe Gaudin⁵, Olivier Brocq⁶, Elisabeth Solau-Gervais⁷, Jean-Marie Berthelot⁸, Jean-Charles Balblanc⁹, Xavier Mariette¹⁰, Florence Tubach¹¹ and Bruno Fautrel¹², ¹Rheumatology Department, Sainte Marguerite Hospital, Marseille, France, ²Department of Rheumatology, Hôpital Lapeyronie, Montpellier, France, ³Biostatistics, Bichat Hospital, AP-HP, Paris, France, ⁴Le Mans Hospital, Le Mans, France, ⁵Rheumatology Department, CHU Hôpital Sud, Grenoble Teaching Hospital, Echirolles, France, ⁶Hospital of Princesse Grâce de Monaco, Monaco, France, ⁷Rheumatology, University Hospital of Poitiers, Poitiers, France, ⁸Rheumatology Unit, Nantes University Hospital, Nantes, France, ⁹Rheumatology, Centre Hospitalier Général de Belfort, Belfort, France, ¹⁰Rheumatology Service, Bicêtre University Hospital, Le Kremlin Bicetre, France, ¹¹INSERM, Universite Paris Diderot, Paris, France, ¹²Paris 6 – Pierre et Marie Curie University; AP-HP, Rheumatology, Pitié-Salpêtrière Hospital, - GRC-UPMC 08 – EEMOIS, Paris, France
Background/Purpose: The STRASS trial was a 18-month randomized controlled trial, conducted in established RA patients in DAS28 remission with etanercept (ETA) or adalimumab (ADA), comparing…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].